206. Fragile X syndrome Clinical trials / Disease details

Clinical trials : 108 / Drugs : 91 - (DrugBank : 36) / Drug target genes : 52 - Drug target pathways : 77

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01120626 (ClinicalTrials.gov)	September 2009	7/5/2010	Randomized Controlled Study of Donepezil in Fragile X Syndrome	Augmentation of the Cholinergic System in Fragile X Syndrome: A Double-Blind Placebo-Controlled Randomized Study of Donepezil	Fragile X Syndrome	Drug: donepezil;Drug: sugar pill	Stanford University	National Institute of Mental Health (NIMH);Autism Speaks	Completed	12 Years	29 Years	All	45	Phase 2	United States
2	NCT00220584 (ClinicalTrials.gov)	July 2005	15/9/2005	An Open-Label Trial of Donepezil in Fragile X Syndrome	An Open-Label Trial of Donepezil in Fragile X Syndrome	Fragile X Syndrome	Drug: donepezil	Stanford University	NULL	Completed	14 Years	N/A	Both	10	Phase 1	United States